Ice cream products distributed in retail stores in nine American states have been recalled due to potential Listeria contamination, according to the United States Food and Drug Administration.
The states involved were New York, Massachusetts, Connecticut, Rhode Island, Vermont, Louisiana, Florida, Texas, and New Hampshire.
The recall was initiated by Royal Ice Cream after FDA sampling revealed Listeria monocytogenes' presence on processing equipment. It has expanded its recall to include all products manufactured at the facility within expiry.
Listeria monocytogenes is an organism that can cause serious and sometimes fatal infections in the young, frail or the elderly, and others with weakened immune systems.
Although healthy individuals may only experience short-term symptoms such as high fever, severe headache, stiffness, nausea, abdominal pain, and diarrhea. Listeria infection can also cause miscarriages and stillbirths among pregnant women.
Officials say all affected products will have the manufacturing plant number “CT121” or “CT#121”.
The affected brands were Royal Ice Cream, Batch brand, Ronny Brook Ice cream, New Orleans Ice cream, Maple Valley Ice Cream, Art Cream, Sweet Scoops Yogurt, Gelato Fiasco, Biggy Iggy’s Ice Cream Sandwiches, Munson Chip Wich Ice Cream sandwiches, Giffords Ice cream Sandwiches, Chewy Louie Ice Cream Sandwiches, Snow Wich Ice Cream Sandwich, and Newport Creamery.
So far, no illnesses have been reported related to the product. Those who have purchased the affected products are urged to return them to the place of purchase for a full refund.


Chip Stocks Rally on AI Optimism as Oil Price Surge Adds Market Tension
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Iran Proposes Strait of Hormuz Reopening Deal Amid Stalled U.S. Talks
Brazil Current Account Deficit Widens in March as FDI Misses Expectations
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation
Global PCB Prices Surge Amid Middle East Conflict and Supply Chain Disruptions
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy
The four types of dementia most people don’t know exist 



